This monthly report outlines key developments in China’s antitrust sector for May. The following events merit special attention...more
5/28/2025
/ Abuse of Power ,
Acquisition Agreements ,
Anti-Competitive ,
Anti-Monopoly ,
Antitrust Investigations ,
Antitrust Provisions ,
Antitrust Violations ,
China ,
Competition ,
DuPont ,
Enforcement Actions ,
Merger Agreements ,
Merger Controls ,
Monopolization ,
Popular ,
State Administration for Market Regulation (SAMR)
On May 9, 2025, the Tianjin Municipal Administration for Market Regulation (“Tianjin AMR”) announced administrative penalties against four manufacturers of dexamethasone sodium phosphate (“DSP”) active pharmaceutical...more
5/27/2025
/ Anti-Monopoly ,
Antitrust Provisions ,
Antitrust Violations ,
Cartels ,
China ,
Competition ,
Coronavirus/COVID-19 ,
Corporate Governance ,
Enforcement Actions ,
Healthcare ,
Life Sciences ,
Monopolization ,
Penalties ,
Pharmaceutical Industry ,
Popular ,
Price-Fixing ,
Regulatory Oversight ,
Sanctions
This monthly report outlines key developments in China’s antitrust sector for April. The following events merit special attention...more
4/17/2025
/ Abuse of Dominance ,
Acquisition Agreements ,
Antitrust Provisions ,
China ,
Competition ,
Corporate Sales Transactions ,
Enforcement Actions ,
Government Agencies ,
Hong Kong ,
Merger Agreements ,
Merger Controls ,
Monopolization ,
New Guidance ,
Penalties ,
Pharmaceutical Industry ,
State Administration for Market Regulation (SAMR)
On March 4, 2025, CK Hutchison Holdings Limited (“CK Hutchison”), controlled by the Li Ka-Shing family, announced a significant transaction on the Hong Kong Stock Exchange: the proposed sale of 80% equity in its port business...more
3/24/2025
/ Antitrust Provisions ,
BlackRock ,
CFIUS ,
China ,
Competition ,
Foreign Investment ,
Hong Kong ,
International Trade ,
Merger Controls ,
Mergers ,
National Security